We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




AI-Powered Chatbots Drive Global Savings of USD 3.6 Billion by 2022

By HospiMedica International staff writers
Posted on 30 Oct 2017
Annual cost savings derived from the adoption of chatbots in healthcare could reach USD 3.6 billion globally by 2022, up from an estimated USD 2.8 million in 2017, marking an average growth of 320% per annum, as AI (artificial intelligence) powered chatbots will drive improved customer experiences for patients. More...
Patients will be able to use sophisticated chatbot systems to access care more quickly and easily, thereby improving access to care and reducing pressure on overworked healthcare systems by ensuring more efficient interactions.

These are the latest findings of Juniper Research (Hampshire, UK), a provider of research and analytical services to the global hi-tech communications sector.

Chatbots, when used to triage patients, can have a dramatic impact on healthcare efficiency. However, chatbots face significant challenges in developed healthcare systems, such as those in the US and UK. Systems in a mature stage of development are usually more conservative in introducing new technology than others, thus resulting in inefficient care. This conservatism is expected to slow down the adoption of chatbot in comparison to the emerging markets such as China and India, where small-scale deployments are already taking place.

Over the next five years, chatbot deployment will be dominated by the Far East and China, with over half of the annual savings realized by chatbots to be contributed by this region in 2022. The varied quality of care in countries such as China will make chatbots useful for directing patients to appropriate services, thereby driving their adoption.

Service providers need to focus on overcoming the current poor level of interoperability of many healthcare IT systems in order to enable chatbots to unlock the full benefits possible. Additionally, data security also remains critical for maintaining patient trust.

Related Links:
Juniper Research


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Portable Digital Floor Scale
DR400C
New
Captivator EMR Device
Captivator Endoscopic Mucosal Resection Device
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: the deep tissue in vivo sound printing (DISP) platform, which combines ultrasound with low-temperature–sensitive liposomes loaded with crosslinking agents (Photo courtesy of Elham Davoodi and Wei Gao/Caltech)

New Ultrasound-Guided 3D Printing Technique to Help Fabricate Medical Implants

3D bioprinting technologies hold considerable promise for advancing modern medicine by enabling the production of customized implants, intricate medical devices, and engineered tissues designed to meet... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.